Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of Nebraska
South Plains Oncology Consortium
The Lymphoma Academic Research Organisation
Jonsson Comprehensive Cancer Center
St. Jude Children's Research Hospital
Therapeutic Advances in Childhood Leukemia Consortium
Barbara Ann Karmanos Cancer Institute
Children's Oncology Group
Northwestern University
National Institutes of Health Clinical Center (CC)
Virginia Commonwealth University
National Cancer Institute (NCI)
National Cancer Institute (NCI)